Search the Newsreel

IKT|Inhibikase Therapeutics Inc|Price:2.217|Chg%:-0.093

Inhibikase Therapeutics Inc (IKT) shows strong fundamentals and high growth potential, despite recent technical trends not fully supporting its performance. The company is considered fairly valued and has high institutional ownership. Analysts have given it a "Buy" rating with a target price indicating significant …

Companhia Siderurgica Nacional SA (SID) Institutional Confidence

The article details the institutional confidence score for Companhia Siderurgica Nacional SA (SID), which is 5.00, placing it 48th in the Metals & Mining industry. Institutional shareholding has increased by 29.07% quarter-over-quarter, with the largest institutional shareholder being James Simons. It also lists several …

National Health Investors Appoints First Chief Operating Officer

National Health Investors (NHI) has appointed Christian (Chris) Maingot as its first Chief Operating Officer, a move intended to bolster its operational strength and expand its senior housing portfolio. Maingot brings over two decades of senior housing experience, including leadership roles at Longview Senior …

Companhia Siderurgica Nacional SA (SID) Stock Score & Comprehensive Stock Analysis - TradingKey

This article provides a comprehensive stock analysis of Companhia Siderurgica Nacional SA (SID) from TradingKey, highlighting its financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. Despite its strong profit growth and undervalued status, the company faces risks like lower market …

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Cash Flow

This article provides a detailed cash flow statement for Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS), covering quarterly and annual data with year-over-year changes across operating, investing, and financing activities. It also includes an FAQ section explaining key cash …

Inhibikase Therapeutics Inc (IKT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Inhibikase Therapeutics Inc (IKT), highlighting its current valuation score of 6.53 and its ranking within the Biotechnology & Medical Research industry. It notes the company's P/E ratio is -5.42, which is significantly below its recent high and …

INBX|Inhibrx Biosciences Inc|Price:82.350|Chg%:+0.800

This article provides a comprehensive stock analysis of Inhibrx Biosciences Inc (INBX), highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. Despite a predicted medium-term downtrend, multiple analysts rate it as "Buy" with a high …

SID|Companhia Siderurgica Nacional SA|Price:0.910|Chg%:-0.034

This article provides a detailed company profile of Companhia Siderurgica Nacional SA (SID), a Brazil-based company operating in steel, mining, logistics, cement, and energy sectors. It includes information on its business scope, key executives, and institutional shareholding data. The company's diverse operations span the …

Fluxo de Caixa de Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS)

This article provides a detailed quarterly cash flow statement for Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS). It includes operational, investment, and financing cash flows, along with historical data and year-over-year percentage changes. The report aims to help users …

Companhia Siderurgica Nacional SA (SID) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Companhia Siderurgica Nacional SA (SID), listing major institutional shareholders and their proportional holdings. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activity with changes in holdings for specific firms. The …

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Institutional Confidence

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) has an institutional shareholding score of 3.00, placing it 11th out of 14 in the Water & Related Utilities industry. The latest institutional shareholding proportion increased by 4.74% quarter-over-quarter to 11.53%. Manning …

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Financial Health: Profitability & Balance Sheet Analysis — TradingKey

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) has a robust financial status, ranking 2 out of 14 in the Water & Related Utilities industry with a financial score of 8.39, an increase of 0.17 since the previous score. The …

Inhibrx Biosciences, Inc. $INBX Shares Bought by SummitTX Capital L.P.

SummitTX Capital L.P. significantly increased its stake in Inhibrx Biosciences (NASDAQ:INBX) by 66.3% during the first quarter, now owning 137,821 shares valued at approximately $9.3 million. Other institutional investors also adjusted their holdings, with institutional investors and hedge funds collectively owning 82.46% of the …

New COO for National Health Investors (NYSE: NHI) to lead operations

National Health Investors, Inc. (NHI) has appointed Christian “Chris” Maingot as its first Chief Operating Officer, effective July 27, 2026. Maingot, with over 20 years of senior housing experience, will receive an initial annual base salary of $415,000, along with performance-based cash incentives and …

SID|Companhia Siderurgica Nacional SA|Price:1.080|Chg%:+0.015

This article provides a detailed company profile of Companhia Siderurgica Nacional SA (SID), a Brazil-based company operating in steel, mining, logistics, cement, and energy sectors. It includes information on its business scope, key executives, and institutional shareholding data. The company's diverse operations span the …

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Income Statement - Tradingkey.com

This TradingKey.com article provides a detailed income statement for Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS), covering quarterly and annual financial performance over several fiscal years. It includes key metrics such as total revenue, cost of revenue, operating expenses, …

Companhia Siderurgica Nacional SA

IKT|Inhibikase Therapeutics Inc|Price:2.330|

This article provides an analysis of Inhibikase Therapeutics Inc (IKT), highlighting its healthy fundamentals, high growth potential, and "Buy" rating from analysts with a target price of $6.00. Despite strong stock performance and outperforming fundamentals, technical indicators suggest the stock is trading sideways, suitable …

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Inhibikase Therapeutics (Nasdaq: IKT) announced that the FDA has granted Orphan Drug Designation (ODD) to its lead product candidate IKT-001 for the treatment of Pulmonary Arterial Hypertension (PAH). This designation highlights the significant unmet medical need for the approximately 50,000 PAH patients in the …

Inhibrx Biosciences Inc (INBX) Cash Flow

This article provides a comprehensive overview of Inhibrx Biosciences Inc's (INBX) cash flow statement, breaking down quarterly and annual data for operating, investing, and financing activities. It features detailed financial figures for various cash flow components, including net income, capital expenditures, and changes in …

Inhibikase Therapeutics Inc (IKT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of the dividend and stock split history for Inhibikase Therapeutics Inc (IKT). It notes that the company has not distributed any dividends in the past five years. The article also details multiple 6-to-1 merger-based stock splits that occurred on …

Inhibrx Biosciences, Inc. Revenue Breakdown – NASDAQ:INBX

Inhibrx Biosciences, Inc. (NASDAQ: INBX) generated $1.30 million USD in revenue last year, primarily from its Biologic Therapeutic segment. This represents a significant increase from the previous year's $200,000 USD. The United States was the company's largest contributor to revenue.

Inhibrx Biosciences Inc (INBX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Inhibrx Biosciences Inc (INBX), listing major shareholders and their respective proportions. It also presents institutional shareholding trends over several quarters and highlights shareholder activity, including changes in holdings for key investors. Additionally, the article includes a section …

Inhibikase Therapeutics (NASDAQ:IKT) Rating Increased to Sell at Wall Street Zen

Wall Street Zen has upgraded Inhibikase Therapeutics (NASDAQ:IKT) from "strong sell" to "sell." This decision comes amidst varied analyst opinions, with some maintaining "sell" ratings while others have initiated "strong-buy" or "outperform" ratings with price targets of up to $5.00. The company's stock opened …

Companhia Siderurgica Nacional Revenue Breakdown – BMFBOVESPA:CSNA3F

Companhia Siderurgica Nacional (CSNA3F) generated 44.80 billion BRL in revenue last year, with its Steel segment being the top performer, contributing 22.03 billion BRL. The majority of the company's revenue, 22.29 billion BRL, came from Brazil.

National Health Investors, Inc. $NHI Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its stake in National Health Investors (NHI) by 4.2% in the first quarter, selling 22,500 shares. Despite this, other institutional investors increased their holdings, and company insiders, including CEO D. Eric Mendelsohn and Director Robert A. McCabe …

Companhia Siderurgica Nacional ADR Cert Deposito Arg Repr 8 Sp ADRs Revenue Breakdown – BCBA:SID

Companhia Siderurgica Nacional (SID) generated 11.84 trillion ARS in revenue last year, with its Steel segment being the top performer, contributing 5.82 trillion ARS. The largest portion of revenue, 5.89 trillion ARS, originated from Brazil. This breakdown highlights the key sectors and geographical areas …

National Health Investors, Inc. Revenue Breakdown – NYSE:NHI

National Health Investors, Inc. (NYSE: NHI) generated $271.60 million in total revenue last year, with its Real Estate Investments segment being the highest contributor at $295.57 million. The majority of the company's revenue, $375.63 million, originated from the United States. This indicates a strong …

Companhia de Saneamento Basico do Estado de Sao Paulo SABESP Registered Shs Cert Deposito Arg Repr 1 Shs

Companhia de Saneamento Basico do Estado de Sao Paulo SABESP's financial performance shows that its Sanitation segment was its top-performing segment last year, generating 6.25 trillion ARS, up from 4.98 trillion ARS the previous year. Brazil was the largest contributor to revenue, accounting for …

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages — TradingKey

This article provides a technical analysis of Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS), detailing its current price momentum, support and resistance levels, and various technical indicators. It offers a breakdown of market performance, including moving averages, and answers …

SBS|Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP|Price:5.625|Chg%:-0.105

Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) (SBS) is a water and sewage service provider showing healthy fundamentals and high growth potential, though its valuation is considered fairly priced. The company has a high institutional ownership and multiple analysts rate it …

Is National Health Investors (NHI) Undervalued As Its Share Price Nears Fair Value?

National Health Investors (NHI) has shown recent strong share price performance and holds a fair value estimate of $85.75 against its current price of $81.10, indicating it is approximately 5.4% undervalued. This valuation is largely driven by its SHOP segment growth and potential accretive …

ELP stock trades steady as Copel earnings and dividend policy shape investor expectations

Copel's (ELP) stock performance is primarily influenced by its regulated electricity operations, recent earnings, and dividend policy. The Brazilian utility reported significant revenue growth of 12.5% and a 24% increase in net income for fiscal 2025, leading to a 25% increase in dividends and …

Companhia Siderúrgica Nacional faces liquidity crunch despite asset sales and stock rally.

Companhia Siderúrgica Nacional (SID) is grappling with a liquidity crisis, marked by four consecutive quarters of cash burn and an inability to reduce debt organically. The company is relying on asset sales, particularly its cement unit, to improve its financial position, but faces delays …

Inhibikase's IKT-001 gets FDA orphan designation for PAH, about 50,000 Americans

Inhibikase Therapeutics announced that its lead product candidate, IKT-001, has received Orphan Drug Designation (ODD) from the U.S. FDA for the treatment of Pulmonary Arterial Hypertension (PAH), a condition affecting approximately 50,000 Americans. This designation provides incentives such as tax credits, exemption from FDA …

Militia Capital Management LLC Makes New $2.46 Million Investment in National Health Investors, Inc. $NHI

Militia Capital Management LLC has made a new investment of $2.46 million in National Health Investors, Inc. (NYSE:NHI) by acquiring 30,400 shares in the first quarter. This makes Militia Capital Management LLC own about 0.06% of the company's stock. Other institutional investors also adjusted …